These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12238450)

  • 1. Anti-HIV agents. Tenofovir looks good in initial therapy.
    TreatmentUpdate; 2002 Aug; 14(6):3-5. PubMed ID: 12238450
    [No Abstract]   [Full Text] [Related]  

  • 2. Tenofovir--long term results from first-line therapy.
    TreatmentUpdate; 2003; 15(2):4-6. PubMed ID: 12693361
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
    MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158
    [No Abstract]   [Full Text] [Related]  

  • 4. [Further indications for tenofovir].
    Dtsch Med Wochenschr; 2003 Sep; 128(39):2037. PubMed ID: 14565207
    [No Abstract]   [Full Text] [Related]  

  • 5. Tenofovir helps beat hepatitis B.
    TreatmentUpdate; 2003 Jan; 15(1):4. PubMed ID: 12630369
    [No Abstract]   [Full Text] [Related]  

  • 6. Tenofovir: Gilead applies for approval; expanded access liberalized.
    Gilden D
    AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenofovir DF on the horizon. Investigational nucleotide reverse transcriptor inhibitor could be on pharmacy shelves soon.
    Eagan L
    Posit Living; 2001; 10(5):21. PubMed ID: 11693102
    [No Abstract]   [Full Text] [Related]  

  • 8. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
    J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [96-week treatment outcome confirms long term efficacy of tenofovir DF].
    Dtsch Med Wochenschr; 2003 May; 128(19):1074-5. PubMed ID: 12774796
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tenofovir--a new option for combination therapy].
    Polk B
    Med Monatsschr Pharm; 2002 Apr; 25(4):140-1. PubMed ID: 12017127
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tenofovir (Viread)].
    Sidahora; 2002; (1):20-1. PubMed ID: 12772661
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome.
    Schaaf B; Aries SP; Kramme E; Steinhoff J; Dalhoff K
    Clin Infect Dis; 2003 Aug; 37(3):e41-3. PubMed ID: 12884188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HIV agents. Tenofovir and Videx (ddi) EC--some caution required.
    TreatmentUpdate; 2002 Aug; 14(6):5. PubMed ID: 12238451
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nucleotide analog shows effectiveness in previously treated patients. The new kind of HAART].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():62-4. PubMed ID: 12043078
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of tenofovir.
    AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892609
    [No Abstract]   [Full Text] [Related]  

  • 16. [No comparison with NRTI. Tenofovir is robust against resistance trouble].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():65. PubMed ID: 12043079
    [No Abstract]   [Full Text] [Related]  

  • 17. Promising results for tenofovir.
    AIDS Patient Care STDS; 2000 Jul; 14(7):396. PubMed ID: 10935058
    [No Abstract]   [Full Text] [Related]  

  • 18. French investigators warn of LPV/TDF/ddI interaction.
    Carter M
    IAPAC Mon; 2003 Dec; 9(12):315. PubMed ID: 15055164
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients.
    Miller MD; Margot N; Lu B; Zhong L; Chen SS; Cheng A; Wulfsohn M
    J Infect Dis; 2004 Mar; 189(5):837-46. PubMed ID: 14976601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [First nucleotide analog against HIV. Lowers viral load also in drug resistance].
    MMW Fortschr Med; 2002 Aug; 144(33-34):60-1. PubMed ID: 12380157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.